GeneDx Holdings Corp.
WGS
$70.69
-$4.81-6.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 416.39M | 393.30M | 357.20M | 326.81M | 302.16M |
| Total Other Revenue | 11.15M | 8.89M | 5.13M | 3.33M | 3.29M |
| Total Revenue | 427.54M | 402.19M | 362.32M | 330.14M | 305.45M |
| Cost of Revenue | 129.36M | 122.08M | 118.90M | 114.68M | 111.00M |
| Gross Profit | 298.18M | 280.11M | 243.42M | 215.47M | 194.45M |
| SG&A Expenses | 237.82M | 211.07M | 187.07M | 182.83M | 171.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 439.21M | 392.23M | 356.88M | 344.24M | 328.61M |
| Operating Income | -11.67M | 9.96M | 5.44M | -14.10M | -23.16M |
| Income Before Tax | -21.14M | 2.51M | 1.54M | -38.39M | -52.63M |
| Income Tax Expenses | -116.00K | 424.00K | 130.00K | 186.00K | -343.00K |
| Earnings from Continuing Operations | -21.02 | 2.08 | 1.41 | -38.58 | -52.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.02M | 2.08M | 1.41M | -38.58M | -52.29M |
| EBIT | -11.67M | 9.96M | 5.44M | -14.10M | -23.16M |
| EBITDA | 12.65M | 32.97M | 27.90M | 7.39M | -2.11M |
| EPS Basic | -0.73 | 0.08 | 0.04 | -1.44 | -1.98 |
| Normalized Basic EPS | -0.33 | 0.42 | 0.33 | -0.61 | -0.96 |
| EPS Diluted | -0.75 | 0.06 | 0.02 | -1.44 | -1.99 |
| Normalized Diluted EPS | -0.34 | 0.41 | 0.32 | -0.61 | -0.96 |
| Average Basic Shares Outstanding | 114.58M | 113.31M | 111.61M | 109.65M | 107.56M |
| Average Diluted Shares Outstanding | 115.75M | 114.48M | 112.78M | 109.65M | 107.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |